COVID symptoms persist up to 9 months, even after mild disease … FDA posts safety alert for pulse oximeters … Alzheimer’s drug tops list of ‘most anticipated’ drug launches of 2021 … Providers welcome Biden’s nomination of Brooks-LaSure as next CMS leader
Clinical briefs for Tuesday, Feb. 23
February 22, 2021